Review Article
The need for novel influenza vaccines in low- and middle-income countries: A narrative review
Julia R. Spinardia,
, Karan B. Thakkarb, Verna L. Welchc, Oladayo Jagund, Moe H. Kyawe
Corresponding author
a Vaccine Medical and Scientific Affairs, Emerging Markets, Pfizer Inc., São Paulo, SP, Brazil
b Vaccine Medical and Scientific Affairs, Emerging Markets, Pfizer Inc., Singapore, Singapore
c Vaccine Medical and Scientific Affairs, Pfizer Inc., Pennsylvania, USA
d Real World Strategy and Innovation, IQVIA Inc., New Jersey, USA
e Vaccine Medical and Scientific Affairs, Emerging Markets, Pfizer Inc., Virginia, USA
